NDA 061904 describes ERYTHROMYCIN ETHYLSUCCINATE, which is a drug marketed by
Amneal Pharms,
Ani Pharms,
Cadila Pharms Ltd,
Endo Operations,
Alpharma Us Pharms,
Dista,
Naska,
Parke Davis,
Pharmafair,
Aurobindo Pharma Usa,
Azurity, and
Barr, and is included in fourteen NDAs. It is available from
five suppliers. Additional details are available on the
ERYTHROMYCIN ETHYLSUCCINATE profile page.
The generic ingredient in ERYTHROMYCIN ETHYLSUCCINATE is
erythromycin ethylsuccinate; sulfisoxazole acetyl. There are one hundred and three
drug master file entries for this compound. Additional details are available on the
erythromycin ethylsuccinate; sulfisoxazole acetyl profile page.